Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 165

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Suppression of tumour-specific CD4 + T cells by regulatory T cells is associated with progression of human colorectal cancer

Open access
Betts, Gareth, Jones, Emma, Junaid, Syed, El-Shanawany, Tariq, Scurr, Martin, Mizen, Paul, Kumar, Mayur, Jones, Sion, Rees, Brian, Williams, Geraint, Gallimore, Awen, Godkin, Andrew · 2012 · Gut

Abstract

Background: There is indirect evidence that T cell responses can control the metastatic spread of colorectal cancer (CRC). However, an enrichment of CD4 + Foxp3 + regulatory T cells (Tregs) has also been documented. Objective: To evaluate whether CRC promotes Treg activity and how this influences anti-tumour immune responses and disease progression. Methods: A longitudinal study of Treg activity on a cohort of patients was performed before and after tumour resection. Specific CD4 + T cell responses were also measured to the tumour associated antigens carcinoembryonic antigen (CEA) and 5T4. Results: Tregs from 62 preoperative CRC patients expressed a highly significant increase in levels of Foxp3 compared to healthy age-matched controls (p=0.007), which returned to normal after surgery (p=0.0075). CD4 + T cell responses to one or both of the tumour associated antigens, CEA and 5T4, were observed in approximately two-thirds of patients and one third of these responses were suppressed by Tregs. Strikingly, in all patients with tumour recurrence at 12 months, significant preoperative suppression was observed of tumour-specific (p=0.003) but not control CD4 + T cell responses. Conclusion: These findings demonstrate that the presence of CRC drives the activity of Tregs and accompanying suppression of CD4 + T cell responses to tumour-associated antigens. Suppression is associated with recurrence of tumour at 12 months, implying that Tregs contribute to disease progression. These findings offer a rationale for the manipulation of Tregs for therapeutic intervention.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2011-300970

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 165

Metadata

Authors
Betts, G., Jones, E., Junaid, S., El-Shanawany, T., Scurr, M., Mizen, P., Kumar, M., Jones, S., Rees, B., Williams, G., Gallimore, A., & Godkin, A.
Venue
Gut
Publisher
BMJ
Published
2011-12-29
Volume
61
Issue
8
Pages
1163-1171
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2144734698
Cited by
165
References
2
FWCI
3.68
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Suppression of tumour-specific CD4 + T cells by regulatory T cells is associated with progression of human colorectal cancer. https://app.cochat.ai/papers/10.1136/gutjnl-2011-300970
The paper
Betts, G., Jones, E., Junaid, S., El-Shanawany, T., Scurr, M., Mizen, P., Kumar, M., Jones, S., Rees, B., Williams, G., Gallimore, A., & Godkin, A. (2012). Suppression of tumour-specific CD4 + T cells by regulatory T cells is associated with progression of human colorectal cancer. Gut. https://doi.org/10.1136/gutjnl-2011-300970

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.